PT Cipta Sarana Medika Tbk (IDX:DKHH)
Indonesia · Delayed Price · Currency is IDR 57.00
0.00 (0.00%)
Last updated: Jun 22, 2026, 11:35 AM WIB
IDX:DKHH Revenue
PT Cipta Sarana Medika Tbk had revenue of 37.57B IDR in the quarter ending March 31, 2026, a decrease of -3.33%. This brings the company's revenue in the last twelve months to 146.22B, down -2.94% year-over-year. In the year 2025, PT Cipta Sarana Medika Tbk had annual revenue of 144.87B, down -4.78%.
Revenue (ttm)
146.22B
Revenue Growth
-2.94%
P/S Ratio
0.99
Revenue / Employee
252.98M
Employees
578
Market Cap
145.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 144.87B | -7.27B | -4.78% |
| Dec 31, 2024 | 152.14B | 17.95B | 13.38% |
| Dec 31, 2023 | 134.19B | 34.61B | 34.76% |
| Dec 31, 2022 | 99.58B | -6.08B | -5.75% |
| Dec 31, 2021 | 105.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 8.59T |
| PT Medikaloka Hermina Tbk | 7.22T |
| PT Mitra Keluarga Karyasehat Tbk | 5.45T |
| PT Famon Awal Bros Sedaya Tbk | 2.57T |
| PT Sarana Meditama Metropolitan Tbk | 1.90T |
| PT Bundamedik Tbk | 1.61T |
| PT Murni Sadar Tbk | 1.43T |
| PT Kedoya Adyaraya Tbk | 490.35B |